Corcept’s Warrants Exercised, Invest in Korlym, Pipeline – Analyst Blog – Nasdaq

Nasdaq
Although the exercise of the warrants will dilute Corcept’s share capital base, it will generate capital for the company. Corcept expects to use the proceeds from the warrants to develop its pipeline and further commercialize its lead drug, Korlym. We
Corcepts Warrants Exercised, Invest in Korlym, PipelineZacks.com

all 4 news articles

…read more

Scroll to Top